CTLA4 and cancer: Moreover, various immune phenotypes of senescent T cells have been associated with malignant tumors, such as the downregulation of CD27 and CD28, and the upregulation of CD57, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and killer cell lectin-like receptor subfamily G (KLRG-1) [25].